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Background. The aim of the study was to assess the primary efficacy of robot-assisted microwave ablation and 
compare it to manually guided microwave ablation for percutaneous ablation of liver malignancies. 
Patients and methods. We performed a retrospective single center evaluation of microwave ablations of 368 
liver tumors in 192 patients (36 female, 156 male, mean age 63 years). One hundred and nineteen ablations were 
performed between 08/2011 and 03/2014 with manual guidance, whereas 249 ablations were performed between 
04/2014 and 11/2018 using robotic guidance. A 6-week follow-up (ultrasound, computed tomography and magnetic 
resonance imaging) was performed on all patients. 
Results. The primary technique efficacy outcome of the group treated by robotic guidance was significantly higher 
than that of the manually guided group (88% vs. 76%; p = 0.013). Multiple logistic regression analysis indicated that a 
small tumor size (≤ 3 cm) and robotic guidance were significant favorable prognostic factors for complete ablation.
Conclusions. In addition to a small tumor size, robotic navigation was a major positive prognostic factor for primary 
technique efficacy.
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Introduction
Local ablation therapy has been established as a 
suitable alternative to resection for the treatment 
of tumors in the liver, lung, kidney and bone. It is 
considered a curative treatment for hepatocellular 
carcinoma (HCC) and can prolong the survival of 
patients with unresectable colorectal liver metasta-
ses.1,2 
In recent years, microwave ablation (MWA), 
which is a thermal ablation method, has increas-
ingly been used as an alternative to radiofrequen-
cy ablation (RFA). Although there are only a few 
studies that have compared MWA and RFA, MWA 
seems to have an advantage for the treatment of 
large tumors and tumors near vessels owing to its 
higher energy output.3-5 Although the local recur-
rence rate has decreased owing to technological 
advances such as the development of multi-appli-
cator systems for MWA and increasing application 
experience, surgical resection still seems superior 
with respect to local tumor control.6-9
To achieve optimal therapy results with the best 
possible local tumor control, it is extremely impor-
tant to obtain complete ablation while maintain-
ing a sufficient safety distance.10 Although there 
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are still no uniform guidelines for the minimum 
safety margin (distance between treated tumor and 
ablation margin), most operators assume a safety 
margin of approximately 0.5–1 cm.11-13 To achieve 
this, the microwave applicator (antenna) must be 
positioned with millimeter precision, which can be 
very challenging, especially in the case of several 
overlapping ablation areas. In addition to the com-
mon freehand placement, modern navigation sys-
tems have been introduced to allow 3D planning 
and precise antenna placement.14,15
Unfortunately, there are only a few studies 
of the use of navigation systems, and often only 
with a small number of patients. Although it has 
been shown that modern navigation systems en-
able very accurate antenna placement, it is not yet 
clear whether this also leads to improved primary 
efficacy of the technique.14,16,17 Therefore, the aim 
of this study was to compare the primary efficacy 
of robotic-guided ablation with that of manually 
guided ablation, as evidenced by magnetic reso-
nance imaging (MRI) follow-up after 6 weeks.
Patients and methods
Study design and participant selection
The indications for percutaneous tumor ablation 
were established by a multi-disciplinary tumor 
board. The following exclusion criteria were ap-
plied: coagulation disorders not amendable to sub-
stitution; portal vein, hepatic vein or inferior vena 
cava invasion; extrahepatic metastases; and mul-
tifocal hepatic disease not amenable to complete 
ablation. 
A total of 192 patients underwent either free-
hand or robotic guided microwave ablation from 
08/2011 to 11/2018, inclusive. All procedures were 
performed by the same three experienced interven-
tional radiologists (blinded).
Ethical approval
This single-center retrospective observational 
study was approved by the local ethics commit-
tee. All procedures performed in studies involv-
ing human participants were in accordance with 
the ethical standards of the institutional and/or 
national research committee and with the 1964 
Helsinki declaration and its later amendments 
and the guidelines for Good Clinical Practice from 
the International Conference on Harmonization. 
Informed consent was obtained from all individual 
participants included in the study.
Navigation system and thermoablation 
procedure 
All microwave ablations were performed under 
general anesthesia. During CT scans and anten-
na positioning, control of the respiratory move-
ment was performed by temporary tube discon-
nection. Arterial and portal venous helical CT 
scans (Somatom 16 or Definition Egde, Siemens 
Healthcare, Forchheim, Germany) with a slice 
thickness of 1 mm were acquired.
CT fluoroscopy was used for ablations without 
navigation support, an acquisition mode that al-
lows continuous image update using in-room table 
control. After the initial 2-phase planning CT, the 
antenna was placed during repeated temporary 
breath holds. To verify the correct antenna place-
ment, one unenhanced CT was obtained before 
starting the ablation. If necessary, the antenna was 
repositioned until the whole tumor volume was 
covered.
When using robot navigation, the initial CT data 
was sent to the navigation system (Maxio, Perfint 
Healthcare, Chennai, India).18,19 The desired abla-
tion area and the antenna entry point were defined 
using the planning software, and the trajectory was 
visualized. If necessary, multiple antenna positions 
were planned with overlapping ablation zones. 
After approval of the plan, the robotic arm was 
automatically positioned over the patient and the 
antenna was positioned using the targeting device 
during breath hold. The probes were pushed for-
ward manually along the preplanned path while 
held by the robotic needle holder. Before ablation, 
a CT scan was performed and the antenna posi-
tion was verified by overlaying it with the planned 
trajectory. Consistent docking and absolute regis-
tration of the robotic device was performed using 
a base plate fixed on the ground. The navigation 
system is connected to the local PACS as a DICOM 
node. The images are automatically pushed to the 
navigation system by an auto transfer task after 
successful reconstruction of the 1mm images in the 
CT scanner.
For ablation, either the Acculis  Microwave 
Tissue Ablation (MTA) System (AngioDynamics, 
Latham, NY, USA; Accu2i pMTA Applicator 1.8 
mm diameter in 14 or 19 cm length) or the Emprint 
Ablation System (Medtronic, Minneapolis, USA; 
Emprint™ Percutaneous Antennas 1.8 mm diam-
eter in 15 or 20 cm length) was used, depending 
on tumor configuration and relationship to the sur-
rounding tissue. By comparison of the expected 
ablation zone in the unenhanced scan (typically 
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hypodense) to the initial tumor in the planning 
scan. If there was suspicion of insufficient ablation 
margin repositioning was performed.
After ablation and track ablation, all patients 
underwent a noncontrast multislice CT scan of the 
liver to detect complications. 
 Imaging follow-up
All patients underwent our standard follow-up 
scheme after 6 weeks including CT, MRI with 
hepatospecific contrast agent and ultrasound. 
Further follow-up investigations were only carried 
out using MRI and ultrasound for radiation protec-
tion. The radiographic adjudication/visual assess-
ment of the complete success of the ablation was 
retrospectively determined in consensus by two 
experienced radiologists (blinded). The primary 
technique efficacy was defined as the percentage of 
the target tumors that were successfully eradicated 
following the initial procedure as evidenced in the 
6-week follow up according to the standardization 
of terminology by Ahmed et al. 20 
 Statistical analysis
R 3.51 was used to perform all statistical calcula-
tions. A p-value of p ≤ 0.05 was considered the cut-
off point of statistical significance. For multivari-
ate analysis of primary efficacy using nested data 
(multiple ablations per patient in some cases), we 
applied generalized estimation equations (GEEs).
Results
Patient characteristics
A total of 192 patients (156 male) were included in 
the study (Table 1). The median age was 64 years 
(range: 57–72). In total, 264 ablation sessions were 
performed with a median number of treatment 
sessions per patient of 1 (range: 1–4). 137 patients 
required one session, 41 patients required two ses-
sions and the remaining patients required three 
or more sessions. The median number of tumors 
treated per patient was 1 (range: 1–9).
Tumor characteristics
A total of 368 tumors spread across all liver seg-
ments were treated using MWA and either robot-
ic-assistance or CT fluoroscopy (Table 2). The two 
most frequent tumor entities were hepatocellular 
carcinoma (n = 271) and liver metastasis of colorec-
tal carcinoma (n = 54), followed by cholangiocellu-
lar carcinoma (n = 18). The median tumor size was 
16 mm, with 59 tumors larger than 30 mm. 
Primary technique efficacy and 
prognostic factors
The primary efficacy rate using robotic guidance 
was 88%, i.e., 219 of the 249 tumors were covered 
completely by the ablation volume. Needle reposi-
tioning was necessary in 92 of 249 ablations (37%). 
In contrast, the primary efficacy rate for freehand 
TABLE 1. Patient characteristics
Age, years Sex, n, (%) Treated tumors per patient, n Tumor entity, n (%)
Min. Mean (SD) Median (IQR) Max. Male Female
Median 
(IQR) Max. HCC CRC CCC Other
Patients 



















CCC = cholangiocellular carcinoma; CRC = colorectal liver metastasis; HCC = hepatocellular carcinoma; IQR = interquartile range; SD = standard deviation
TABLE 2. Tumors treated using freehand and robotic guidance
Ablation 
technique
Long axis, mm Liver segment, n (%) Device, n (%) Primary efficacy, n (%)































































SD = standard deviation 
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ablation was 76% (91 of 119 tumors). Logistic re-
gression was performed to investigate whether tu-
mor characteristics (size, entity and location) and 
the type of guidance (robotic or freehand) can im-
pact primary technique efficacy (Table 3).
Compared with tumor size ≤ 3 cm, tumor size > 
3 cm was a significantly unfavorable prognostica-
tor of primary technique efficacy (odds ratio 0.42; 
p = 0.02). Compared with freehand antenna place-
ment, robotic guidance was a significant favorable 
prognostic factor (odds ratio 2.24; p = 0.01). Table 4 
shows estimations of the primary technique effi-
cacy for robotic and freehand guidance.
Adverse events
141 (80.11%) of the robotic-guided and 62 (70.45%) 
of the CT-fluoroscopy-guided procedures were 
performed without any adverse events. Grade I 
(mild), II (moderate) and III (severe) adverse events 
occurred in 9 (5.11%), 6 (3.41%) and 1 (0.57%) of 
the robotic-guided procedures, respectively, and 3 
(3.41%), 3 (3.41%) and 1 (1.14%) of the freehand-
guided procedures, respectively.
Grade IV (life-threatening) adverse events oc-
curred in 1 (0.57%) of the robotic-guided proce-
dures and 2 (2.27%) of the freehand-guided pro-
cedures. The patient in the robotic-guided group 
suffered an injury to the 10th intercostal artery 
during ablation, which led to persistent bleeding 
and had to be treated with embolization. One of 
the patients in the freehand group, who had previ-
ously undergone partial liver resection and a con-
secutive Chilaiditi situation, had a perforation of a 
prolapsed intestinal loop that had to be surgically 
overstitched. The other patient in the freehand 
group suffered from bleeding from the 7th and 8th 
intercostal artery after ablation, which had to be 
closed by embolization.
Treatment-related patient death (Grade V) oc-
curred in 1 (0.57%) of the robotic-guided proce-
dures and 0 (0.00%) of the freehand guided pro-
cedures. A patient that had a previous liver and 
kidney transplant developed severe cholangitis 
two days after ablation and subsequent liver and 
kidney failure with lactate acidosis, which could 
not be controlled despite ultima ratio crush hepa-
tectomy.
There was no significant difference in the fre-
quency of adverse events (p = 0.07) between the 
two groups.
Discussion
In recent years, the importance of local ablative 
procedures for the treatment of liver tumors has 
steadily increased. It is well-known that an initial 
complete response is associated with improved 
survival from hepatocellular carcinoma and colo-
rectal liver metastasis.10,21 Therefore, the exact 
placement of the antenna is critically important to 
achieve complete ablation with a sufficient safety 
margin. 
Navigation procedures are increasingly used to 
assist with accurate antenna placement. We have 
also switched from manual guidance to navigation 
in almost all cases. Only in very few cases (tumor 
TABLE 3. Influence of tumor characteristics on primary efficacy
Predictor Estimate Std.err Wald p-value
Long axis, mm
≤ 30 Reference
> 30 − 0.8717 0.3657 5.68 0.0171
Guidance
Freehand Reference
Robotic 0.8064 0.3256 6.13 0.0133
Tumor entity
HCC Reference
CRC 0.2922 0.4483 0.42 0.5145
CCC 0.0665 0.6524 0.01 0.9188
Other 0.0832 0.5228 0.03 0.8736
Liver segment
I Reference
II − 0.3956 1.0798 0.13 0.7141
III − 0.0449 1.1025 0.00 0.9675
IVa 0.2688 1.1180 0.06 0.8100
IVb − 0.2539 1.1597 0.05 0.8267
V 0.5961 1.1285 0.28 0.5974
VI 0.9036 1.1736 0.59 0.4413
VII 0.0656 1.1090 0.00 0.9528
VIII − 0.1069 1.0929 0.01 0.9221
CCC = cholangiocellular carcinoma; CRC = colorectal liver metastasis; HCC = hepatocellular 
carcinoma; Wald = χ2 test for the coefficients
TABLE 4. Monte Carlo simulation of primary technique efficacy 




Guidance CI-2.5% Median CI-97.5%
≤ 30 Freehand 0.60 0.75 0.86
> 30 Freehand 0.34 0.55 0.76
≤ 30 Robotic 0.78 0.87 0.92
> 30 Robotic 0.55 0.74 0.87
CI-2.5% and CI-97.5% = the central interval bounds at the lower 2.5 and 
upper 97.5 percentiles, respectively; Median = the simulated distribution’s 
median
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right below diaphragm or right next to stomach) 
we switched to manual placement for better con-
trol. Although a very high accuracy of the robot-
supported placement has already been shown14,18 
until now, it has not been clear whether this im-
proves the primary efficacy, i.e., the percentage of 
target tumors successful eradicated.
Studies have shown that the robotic-guided 
approach improves the accuracy of targeting the 
tumor, reduces patient radiation dose and in-
creases procedural performance when compared 
with conventional non-navigated antenna place-
ment.14,22-24 Other studies claim that there is no sta-
tistically significant reduction in the dose between 
the robotic-assisted and conventional method.25 In 
one of our earlier studies, we showed that robotic 
assistance for liver tumor ablation reduces the pa-
tient radiation dose and allows a fast positioning 
of the microwave applicator with high accuracy.18 
Due to the small number of patients (n = 46) we 
could not show any significant difference in the 
primary efficacy rate. In one of our previous stud-
ies, we were able to show that additional overhead 
does not save time in the case of only one tumor, 
and that savings can only be expected in complex 
procedures.26
Although these previous studies have shown 
that antenna placement is highly accurate when us-
ing a robotic-guided navigation system, the impact 
of higher accuracy on the technical efficacy has 
not been investigated. In this study, we show for 
the first time in a large patient population (249 tu-
mors ablated using robotic assistance) that robotic 
guidance is associated with a significantly higher 
technical success rate (primary efficacy rate using 
robotic guidance was 88%, primary efficacy rate 
for freehand ablation was 76%). From our point of 
view, this difference is very remarkable, because 
we had many years of expertise in manual guid-
ance and still managed to achieve this improve-
ment with the new type of navigation.
Although the large patient population indicates 
a high significance, some limitations have to be dis-
cussed. One aspect that needs to be considered is 
that interindividual differences could play a role. 
However, from our point of view, the high experi-
ence and the large number of ablations of each in-
terventionalist speak against great interindividual 
differences. In addition, the learning curve also 
plays a role, which undoubtedly occurs over time, 
as Beermann et al. also stated.27 
In summary, our study was the first to show 
that robotic-guided antenna placement goes hand 
in hand with a higher primary efficacy.
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